Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlackrock I&g Regulatory News (BRIG)

Share Price Information for Blackrock I&g (BRIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 188.50
Bid: 188.00
Ask: 189.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.532%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 188.50
BRIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Update

20 Aug 2021 17:58

BlackRock Income and Growth Investment Trust Plc - Portfolio Update

BlackRock Income and Growth Investment Trust Plc - Portfolio Update

PR Newswire

London, August 20

The information contained in this release was correct as at 31 July 2021. Information on the Company’s up to date net asset values can be found on the London Stock Exchange Website at:

https://www.londonstockexchange.com/exchange/news/market-news/market-news-home.html.

BLACKROCK INCOME & GROWTH INVESTMENT TRUST PLC (LEI:5493003YBY59H9EJLJ16)

All information is at 31 July 2021 and unaudited.

Performance at month end with net income reinvested

One MonthThree MonthsOne YearThree YearsFive YearsSince 1 April 2012
Sterling
Share price6.2%7.4%32.5%6.5%28.7%106.6%
Net asset value-0.1%0.9%23.8%4.0%28.2%92.4%
FTSE All-Share Total Return0.5%1.8%26.6%5.5%32.3%87.4%
Source: BlackRock

BlackRock took over the investment management of the Company with effect from 1 April 2012.

At month end

Sterling:

Net asset value – capital only:198.29p
Net asset value – cum income*:199.87p
Share price:195.00p
Total assets (including income):£43.5m
Discount to cum-income NAV:2.4%
Gearing:5.8%
Net yield**:3.7%
Ordinary shares in issue***:21,742,207
Gearing range (as a % of net assets):0-20%
Ongoing charges****:1.2%
* Includes net revenue of 1.58 pence per share
** The Company’s yield based on dividends announced in the last 12 months as at the date of the release of this announcement is 3.7% and includes the 2020 final dividend of 4.60p per share declared on 01 February 2021 and paid to shareholders on 17 March 2021 and the 2021 interim dividend of 2.60p per share declared on 23 June 2021 with a pay date of 1 September 2021.
*** excludes 10,081,532 shares held in treasury
**** Calculated as a percentage of average net assets and using expenses, excluding performance fees and interest costs for the year ended 31 October 2020.

Sector AnalysisTotal assets (%)
Support Services12.3
Financial Services8.7
Pharmaceuticals & Biotechnology8.3
Household Goods & Home Construction7.9
Mining6.8
Oil & Gas Producers5.5
Personal Goods5.3
Media4.7
Banks4.6
Life Insurance4.5
Tobacco3.7
Travel & Leisure3.5
Nonlife Insurance3.4
General Retailers3.3
Health Care Equipment & Services2.8
Food & Drug Retailers2.0
General Industrials1.9
Electricity1.4
Electronic & Electrical Equipment1.4
Industrial Metals & Mining1.3
Food Producers1.1
Real Estate Investment Trusts1.0
Technology Hardware & Equipment0.7
Industrial Engineering0.7
Real Estate Investment & Services0.1
Net Current Assets3.1
-----
Total100.0
=====

Country AnalysisPercentage
United Kingdom90.0
United States3.5
France1.9
Italy1.3
Sweden0.2
Net Current Assets3.1
-----
100.0
=====

Top 10 holdingsFund %
AstraZeneca6.4
RELX4.7
Rio Tinto4.6
Reckitt Benckiser4.1
Unilever4.1
Royal Dutch Shell ‘B’3.8
British American Tobacco3.7
Ferguson3.1
3i2.8
Smith & Nephew2.8

Commenting on the markets, the Investment Manager noted:

Performance Overview:

The Company returned -0.1% during the month, underperforming the FTSE All-Share Index which returned 0.5%. 

Market Summary:

In July, global equity markets were modestly up, however, volatility was high throughout the month due to the increasing number of COVID-19 Delta variant cases and rapid swings of sentiment regarding inflation expectations. Both EU and US equities reached record highs in the first part of the month followed by a significant sell-off and a partial rebound in the second half of July.

10-year U.S. Treasury yields retracted to 1.18%1 (the lowest in 5 months) around mid-July and pulled back up slightly after. According to the U.S. Department of Labor, inflation surged at its fastest pace in nearly 13 years, as the Consumer Price Index (CPI) increased 5.4%2 from a year earlier. Oil prices decreased in July as a result of the Organization of the Petroleum Exporting Countries (OPEC), the oil cartel, agreeing to boost supply driving the valuation of the Energy sector lower.

The UK was hit with disruptions by the “pingdemic” where the NHS Test and Trace application closed down parts of the UK economy despite the government’s attempts to lift remaining lockdown restrictions on “Freedom Day”. The UK vaccination rollout continued to prove strength with over 70% of the population fully inoculated3. England’s participation in the Euro Cup Finals provided a boost to retail sales and the travel and leisure sector also saw a boost later in the month with the announcement of restrictions on inbound arrivals to the UK being eased.

The FTSE All Share Index rose 0.5% with Basic Materials, Technology and Industrials as top performing sectors while Telecommunication, Oil & Gas, and Health Care were top underperformers.

Stocks:

Rentokil was a top positive contributor during the month; the company delivered a strong set of results with revenues accelerating as workplaces reopened and mobility increased. RELX was another top contributor; the company also reported a guidance upgrade, despite continued weakness in its exhibitions business with revenue and profit growth guided to be above historical levels. Another company with a strong statement was 3i as the valuation of their largest position Action, the discount retailer, grew strongly during the first half. 

Reckitt Benckiser was the top detractor from the portfolio on the back of the release of a disappointing earnings statement; margin guidance was lowered primarily as a function of higher input costs and dilution from M&A. Smith & Nephew also detracted from the portfolio despite releasing a strong earnings statement where revenues grew by almost 50% since the last quarter.

Portfolio Activity:

During the period, we did not purchase nor sell any holdings. We reduced Smiths Group and Rio Tinto. We also added to Tate & Lyle.

Outlook:

After five years under a Brexit-induced cloud, the relative position of the UK in the eyes of global investors appears to have improved, helped by the vaccination programme, and evidenced by the resurgence in takeover activity as bidders look to capitalise on the discount at which UK equities trade relative to global peers. Specifically, we’ve seen acquisitions of real assets potentially demonstrating a desire to find unlevered free cash flow.

The pandemic has generated an economic cycle unlike any other with unprecedented fiscal and monetary responses. Despite the continuation of COVID-19 restrictions globally, economic activity has been less impacted as consumers and corporates in Developed Markets have adapted their behaviours since the development of an effective vaccine. Concerns have been raised around new variants; however, recovery has been buoyed by ongoing monumental monetary and fiscal support.

We have seen during this results season, that the growth in economic activity has caused some strains on supply chains with specific industry shortages as well as building inflationary pressures. Whilst there may be a lag time in companies pricing this inflation leading to short term earnings weakness, we continue to concentrate on owning those businesses who display pricing power in the long term. We continue to monitor the bond market to determine if the current surge in inflation is transitory or, fuelled by a more relaxed Fed, a phenomenon that may persist. We are also cognisant of the evolution of relationships between China and the West and the potential impact on industries and shares.

We continue to have conviction in cash-generative companies that have delivered for the portfolio and we foresee delivering into the future. We view the dividend outlook for the UK market with renewed optimism as we expect dividends, in aggregate, to be more resilient and to grow faster in the future as those companies that had been overdistributing for a number of years reset their dividends during the pandemic. Resilience was a crucial feature of the Company and its underlying holdings in 2020 and while this will still be important in 2021, we are excited by the approaching economic recovery and the opportunity to deliver strong capital and dividend growth for our clients over the long-term.

1 Source: MarketWatch, July 2021 https://www.marketwatch.com/story/10-year-treasury-yield-slides-to-5-month-low-below-1-23-116266958662 Source: CNBS, July 2021 https://www.cnbc.com/2021/07/13/consumer-price-index-increases-5point4percent-in-june-vs-5percent-estimate.html3Source: BBC, August 2021 https://www.bbc.com/news/health-55274833

20 August 2021

Date   Source Headline
3rd May 202412:13 pmPRNNet Asset Value(s)
2nd May 202412:10 pmPRNNet Asset Value(s)
2nd May 20247:00 amPRNTotal Voting Rights
1st May 202412:10 pmPRNNet Asset Value(s)
1st May 20247:00 amPRNTotal Voting Rights
30th Apr 20244:04 pmPRNTransaction in Own Shares
30th Apr 202412:07 pmPRNNet Asset Value(s)
29th Apr 20245:02 pmPRNTransaction in Own Shares
29th Apr 202412:25 pmPRNNet Asset Value(s)
29th Apr 20247:00 amPRNTotal Voting Rights
26th Apr 202411:45 amPRNNet Asset Value(s)
26th Apr 20247:00 amPRNTotal Voting Rights
25th Apr 20245:30 pmPRNTransaction in Own Shares
25th Apr 202412:14 pmPRNNet Asset Value(s)
24th Apr 20243:59 pmPRNTransaction in Own Shares
24th Apr 202412:15 pmPRNNet Asset Value(s)
23rd Apr 20244:44 pmPRNPortfolio Update
23rd Apr 202412:13 pmPRNNet Asset Value(s)
22nd Apr 202411:54 amPRNNet Asset Value(s)
19th Apr 202412:06 pmPRNNet Asset Value(s)
19th Apr 20247:00 amPRNTotal Voting Rights
18th Apr 202412:16 pmPRNNet Asset Value(s)
18th Apr 20247:00 amPRNTotal Voting Rights
17th Apr 20246:03 pmPRNTransaction in Own Shares
17th Apr 202412:13 pmPRNNet Asset Value(s)
17th Apr 20247:00 amPRNTotal Voting Rights
16th Apr 20245:49 pmPRNTransaction in Own Shares
16th Apr 202412:02 pmPRNNet Asset Value(s)
16th Apr 20247:00 amPRNTotal Voting Rights
15th Apr 20245:10 pmPRNTransaction in Own Shares
15th Apr 202411:37 amPRNNet Asset Value(s)
15th Apr 20247:00 amPRNTotal Voting Rights
12th Apr 20244:32 pmPRNTransaction in Own Shares
12th Apr 202412:14 pmPRNNet Asset Value(s)
12th Apr 20247:00 amPRNTotal Voting Rights
11th Apr 20243:57 pmPRNTransaction in Own Shares
11th Apr 202412:11 pmPRNNet Asset Value(s)
11th Apr 20247:00 amPRNTotal Voting Rights
10th Apr 20245:18 pmPRNTransaction in Own Shares
10th Apr 202412:06 pmPRNNet Asset Value(s)
10th Apr 20247:00 amPRNTotal Voting Rights
9th Apr 20243:35 pmPRNTransaction in Own Shares
9th Apr 202411:45 amPRNNet Asset Value(s)
9th Apr 20247:00 amPRNTotal Voting Rights
8th Apr 20245:15 pmPRNTransaction in Own Shares
8th Apr 202411:59 amPRNNet Asset Value(s)
8th Apr 20247:00 amPRNTotal Voting Rights
5th Apr 20245:44 pmPRNTransaction in Own Shares
5th Apr 202412:15 pmPRNNet Asset Value(s)
5th Apr 20247:00 amPRNTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.